genomic studies to identify mechanisms of resistance to imids drugs in multiple myeloma
Published 7 years ago • 216 plays • Length 7:08Download video MP4
Download video MP3
Similar videos
-
3:16
leukemia, lymphoma, and multiple myeloma
-
1:56
why is the human genome so important for cancer research?
-
7:57
myeloma and multiple myeloma - everything you need to know | cancer education and research institute
-
9:32
multiple myeloma: genomic evolution
-
4:47
multiple myeloma - mayo clinic
-
9:29
myeloma diagnosis and treatment
-
7:24
andy, multiple myeloma survivor
-
10:20
understanding multiple myeloma (multiple myeloma explained clearly)
-
19:06
lessons in blood cancer: how far we have come
-
20:15
genom perspective podcast – myeloma
-
4:04
discovery of new molecular mutations can help find new treatments
-
10:11
what is multiple myeloma? | hematologic system diseases | nclex-rn | khan academy
-
5:51
tumor immunology: leukemia, lymphoma & myeloma – immunology | lecturio
-
10:30
blood cancers explained: leukemia, myeloma, lymphoma, and more
-
5:22
canadian researcher advancing break-through therapies in blood cancer
-
2:53
what are immunomodulatory drugs (imids) and how do they work?
-
53:44
what's in your blood? a look at leukemia, lymphoma, and multiple myeloma
-
4:07
why is it important for myeloma patients to know the cytogenetic abnormalities of their cancer?
-
2:31
what immunotherapies are used in myeloma? can imids be considered a form of immunotherapy?
-
2:50
what is myeloma?
-
3:35
cancer immunotherapy
-
2:16
a vaccine for myeloma?